Ligand validation:6BPN

POG: (20S)-2,5,8,11,14,17-HEXAMETHYL-3,6,9,12,15,18-HEXAOXAHENICOSANE-1,20-DIOL

POG is a Ligand Of Interest in 6BPN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6BPN_POG_A_808	14%	39%	0.314	0.866	1.13	1.27	-	3	4	0	100%	1
6BPN_POG_A_805	5%	40%	0.364	0.778	1.19	1.17	-	3	4	0	100%	1
6BPN_POG_A_806	5%	47%	0.299	0.702	1.19	0.86	2	-	0	0	100%	1
6BPN_POG_A_807	3%	45%	0.319	0.668	1.17	0.95	-	1	0	0	100%	1
6BPM_POG_C_801	35%	45%	0.23	0.92	1.1	1.01	-	2	6	0	100%	1
5AHW_POG_C_1149	33%	16%	0.17	0.848	1.25	2.37	3	10	18	0	100%	1
3T6A_POG_B_834	33%	16%	0.162	0.914	1.32	2.34	2	6	6	0	59%	0.5862
8HJH_POG_B_501	32%	47%	0.122	0.891	1.11	0.94	-	1	1	0	45%	0.4483
8HJL_POG_A_503	28%	48%	0.205	0.86	1.2	0.83	2	-	2	0	100%	0.7238
8BSG_POG_A_609	23%	48%	0.181	0.846	0.69	1.32	-	2	1	0	76%	0.7586

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.